Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin Ding

Showing results (831-840 of 839) with videos related to

Pageof 84
Sort By:
You have reached the last page of results.This site can display upto 839 results.
Nature|March 4, 2024
Dopant-additive synergism enhances perovskite solar modulesBin Ding, Yong Ding, Jun Peng, et al.
Aging|December 13, 2019
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective studyPei-Yun Zhou, Chao-Ping Yang, Zheng Tang, et al.
Science (New York, N.Y.)|October 31, 2024
Cation reactivity inhibits perovskite degradation in efficient and stable solar modulesYong Ding, Bin Ding, Pengju Shi, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2025
A wireless magnetoelectric-driven strategy to boost nose-to-brain drug delivery with сore-shell nanotransducersRoman V Chernozem, Alexander V Romashchenko, Polina V Chernozem, et al.
The New England Journal of Medicine|March 4, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic CholangiocarcinomaGuo-Ming Shi, Xiao-Yong Huang, Fei Liang, et al.
Nature|May 24, 2023
Flexible solar cells based on foldable silicon wafers with blunted edgesWenzhu Liu, Yujing Liu, Ziqiang Yang, et al.
Eclinicalmedicine|February 18, 2026
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation studyJian-Jian Chen, Zhi-Cheng Jin, Jia-Wei Zhou, et al.
Signal Transduction and Targeted Therapy|February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Pageof 84

Showing results (831-840 of 839) with videos related to

Sort By:
Pageof 84
You have reached the last page of results.This site can display upto 839 results.
Nature|March 4, 2024
Dopant-additive synergism enhances perovskite solar modulesBin Ding, Yong Ding, Jun Peng, et al.
Aging|December 13, 2019
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective studyPei-Yun Zhou, Chao-Ping Yang, Zheng Tang, et al.
Science (New York, N.Y.)|October 31, 2024
Cation reactivity inhibits perovskite degradation in efficient and stable solar modulesYong Ding, Bin Ding, Pengju Shi, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2025
A wireless magnetoelectric-driven strategy to boost nose-to-brain drug delivery with сore-shell nanotransducersRoman V Chernozem, Alexander V Romashchenko, Polina V Chernozem, et al.
The New England Journal of Medicine|March 4, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic CholangiocarcinomaGuo-Ming Shi, Xiao-Yong Huang, Fei Liang, et al.
Nature|May 24, 2023
Flexible solar cells based on foldable silicon wafers with blunted edgesWenzhu Liu, Yujing Liu, Ziqiang Yang, et al.
Eclinicalmedicine|February 18, 2026
Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation studyJian-Jian Chen, Zhi-Cheng Jin, Jia-Wei Zhou, et al.
Signal Transduction and Targeted Therapy|February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Pageof 84